Alternatives to PFx Biotech

AI-powered platform for antibody discovery and development to create new medicines.

Biotech company focused on designing and developing novel biological solutions.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered drug discovery and development platform for biologics.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform for designing novel molecular structures for new medicines.

Biotechnology company

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

AI-powered platform accelerating biological research and drug discovery.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Compressing biology to develop the next generation of therapies.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

AI-enabled technology for cell biology research and biopharma development.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Mapping cell-cell communication at scale in human tissue.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Mining biological information for transformative peptide medicines.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Global marketplace connecting researchers with human biospecimens for life science research.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.